01
Commissioned HTA & Economic Evaluation
Independent HTA and economic evaluations for public agencies, providers and payers — informing reimbursement and coverage decisions.
Industry & Commissioned Work
Rigorous evaluation under transparent academic governance.
ITECH works with pharmaceutical, biotechnology, medical device and health technology partners — combining methodological rigor with independence and transparency.
02
Contract Research
Trial-based economic evaluations, real-world evidence studies, and cost-effectiveness and budget impact modelling.
03
Clinical Trial Economic Analysis
Prospective economic endpoints, PROMs integration, and health-economic analyses embedded within clinical trials.
04
Public-Private Partnerships
Structured collaborations with pharmaceutical, biotechnology, medical device and health technology companies.
Engagement framework
Principled collaboration with industry partners.
Industry collaborations may involve trial-based economic evaluations, real-world evidence studies, cost-effectiveness and budget impact modelling, outcomes research, PROMs integration and methodological consultation aligned with international HTA standards.
All industry-engaged projects adhere to:
- Academic independence
- Conflict-of-interest disclosure policies
- Transparent reporting practices
- Peer-review standards
ITECH supports responsible innovation by ensuring that economic and clinical value are rigorously assessed before integration into healthcare systems.
Engage with ITECH
